This edition of AACR Drug Discovery and Development (AACR D3) has already taken place.
Search future editions βB2B Event
Exhibitor list
We do not have this show's exhibitor list
This show was held in July 2026. We hold no exhibitor list for AACR Drug Discovery and Development (AACR D3) 2026. If the organiser does not make it public, we may never get it. Send us a request and we will try to find the exhibitors by searching.
Ask us to search for itA specialized conference focused on accelerating cancer drug discovery and development, bringing together academic researchers, biotech/pharma professionals, and regulatory agencies. The 2026 event will focus on team-science approaches, novel therapeutics, and bridging discovery with clinical impact.
Exhibitor list
We do not have this show's exhibitor list
This show was held in July 2026. We hold no exhibitor list for AACR Drug Discovery and Development (AACR D3) 2026. If the organiser does not make it public, we may never get it. Send us a request and we will try to find the exhibitors by searching.
Ask us to search for itVenue
Sheraton Boston HotelHotel venue Β· 5,744 mΒ² Β· 26 halls Β· ~3,000 people
A 1,070-room hotel located in Boston's Back Bay, featuring over 61,000 sq ft of meeting space across 26 rooms, with direct access to the Hynes Convention Center.
π 39 Dalton St, Boston, MA 02199, USA
Operated by Marriott International
Organizer
American Association for Cancer ResearchNonprofit Β· Philadelphia, United States Β· Founded 1907
The first and largest cancer research organization dedicated to accelerating the prevention and cure of cancer.
Why people attend
To evaluate new therapeutic platforms, find collaborative partners, and explore specialized services in the oncology pipeline.
Exhibitor categories
Past & future editions
More events in United States
Frequently asked questions